ARKK Holdings of Twist Bioscience (TWST) - Updated Daily
Join Premium Plan
Key Statistics
EarningsSee Full Calendar
| Date | May 05, 2022 | Revenue | Expected0 Actual$48.13m | EPS | Expected-$1.28 Actual-$1.13 |
|---|
Statistics
Institutional Ownership Trends
News That Matters
| Description | |
|---|---|
| Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by 'writing' DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research. | |
| Website | |
| www.twistbioscience.com |
Research Notes and Commentary for TWST
February 7, 2022
February 1-7, 2021: ARK Trades and Storylines
Trading Floor